校正:以线粒体为向和NO为基础的抗癌纳米系统,具有增强的光控制性和低暗毒性
Jiangsheng Xu1, Fang Zeng1, Hao Wu1
1College of Materials Science and Engineering, State Key Laboratory of Luminescent Materials and Devices, South China University of Technology, 510640, China. mcfzeng@scut.edu.cn.
Journal of materials chemistry. B
|May 12, 2025
概括
这次纠正涉及一项关于新型抗癌纳米系统的先前研究. 纠正的信息涉及一种向线粒体,释放氧化 (NO) 的纳米药物,旨在增强光动力学癌症治疗,降低暗毒性.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 针对线粒体的药物对于有效的癌症治疗至关重要.
- 基于氧化 (NO) 的纳米系统为向癌症治疗提供了潜在的潜力.
- 可光控制的药物输送系统可以提高治疗效率并减少副作用.
研究的目的:
- 纠正和澄清以前发表的研究的细节.
- 为了确保准确报告一个线粒体向和NO基抗癌纳米系统.
- 提供关于其光学可控性和暗中毒性的最新信息.
主要方法:
- 纠正原始出版物中的特定数据或陈述.
- 重新评估纳米系统的性能和性能.
- 澄清实验程序和结果的解释.
主要成果:
- 校正确保了纳米系统线粒体准能力的准确表示.
- 更新的信息证实了NO释放抗癌系统的增强光控制能力.
- 修正后的发现强调了开发的纳米系统的低暗毒性.
结论:
- 准确的报告对于基于NO的抗癌纳米医学的进步至关重要.
- 修正后的研究加强了这个纳米系统在光动力学癌症治疗中的潜力.
- 这项工作有助于开发更安全,更有效的癌症治疗策略.
更多相关视频
11:20An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
Published on: August 30, 2017
7.4K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.4K
相关概念视频
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...